As Coursera prepares to release its Q4 results, investors are weighing its steady growth against a challenging backdrop for tech and education stocks. Here’s the breakdown.
StepStone Group is set to report its fourth-quarter earnings after the market closes on Thursday. Analysts project robust revenue growth, but the firm faces a challenging macro backdrop and recent stock underperformance.
All eyes are on Insight Enterprises as it prepares to report Q4 earnings. After a disappointing prior quarter, analysts project flat revenue growth, setting the stage for a critical update on the company's trajectory in a competitive hardware and electronics landscape.
As Omnicell prepares to report quarterly results, investors are watching to see if the medication management specialist can continue its history of exceeding revenue expectations amidst a slowing growth environment.
Alternative investment giant Ares Management (ARES) is scheduled to release its fourth-quarter financial results before Thursday's market open, with analysts anticipating strong year-over-year revenue growth despite recent sector headwinds.
As Exponent (EXPO) prepares to release its fourth-quarter results, investors are weighing whether the firm can sustain its growth trajectory amid a mixed outlook for professional services.
SS&C Technologies (SSNC) is poised to release its fourth-quarter earnings after the bell on Thursday. Investors will be watching to see if the company can extend its impressive track record of surpassing revenue estimates against a backdrop of slowing growth and sector-wide pressure.
As Viasat prepares to release its quarterly results after Thursday's market close, investors are watching for signs of sustained growth amid industry-wide volatility. The satellite communications leader's performance could signal broader trends in the telecom services space.
After years of declining share prices, Pfizer is banking on a pipeline packed with over 20 pivotal Phase 3 trial launches this year to reignite growth and investor confidence.
Amid a sharp sell-off in growth-oriented sectors, risk-averse capital flowed into stable, income-generating giants on Tuesday, highlighting a broader market rotation.
Shares of infrastructure specialist Quanta Services (PWR) defied a broader market downturn, rising over 2% as investors position for the company's upcoming earnings report. The rally extends a strong year-to-date performance, but analysts question if the current price fully reflects future growth prospects.
DCC plc's latest valuation model maintains its fair value estimate per share, though underlying assumptions on discount rates and growth have been fine-tuned, reflecting a more measured analyst outlook.
BigBear.ai's stock fell sharply following the announcement of a major partnership with AD Ports Group's digital arm and a concurrent proposal to potentially double its authorized shares, highlighting investor tension between long-term growth and near-term dilution.
As The New York Times prepares to report its latest quarterly earnings, investors are weighing strong recent performance against valuation concerns. The stock has surged over 25% in 90 days, but analysts debate whether its current price fully reflects future growth prospects and emerging industry challenges.
The Malaysian electrical components firm UMS-Neiken Group Berhad (KLSE:UMSNGB) is showing signs of strain, with its Return on Capital Employed (ROCE) falling to 3.0%—significantly below the industry benchmark. A five-year trend of declining returns on stagnant capital raises questions about its growth trajectory and operational efficiency.
Despite commanding half the U.S. secondary ticket market and a strategic push into primary sales, StubHub Holdings (STUB) trades well below its IPO price. Analysts see a compelling value case as the company leverages its dominant position for growth.
The Clorox Company reported fiscal second-quarter results largely in line with internal forecasts, citing a challenging macro environment and temporary disruptions from its ongoing ERP system implementation. Management highlighted sequential improvement through the quarter and outlined a path to margin recovery and growth driven by innovation in the latter half of the fiscal year.
Benchmark Electronics (BHE) delivered a strong finish to fiscal 2025, with Q4 revenue and earnings surpassing guidance. The company highlighted improving margins, robust cash generation, and growth in key sectors, even as it navigates a planned CEO transition and outlines increased capital investment for the year ahead.
Goldman Sachs, Clear Street, and Bank of America have all significantly raised their price targets for Krystal Biotech (KRYS), citing strong growth from its gene therapy Vyjuvek and a promising pipeline targeting ophthalmic and respiratory diseases.
Following robust year-end financials and guidance, analysts reaffirm bullish stance on Mobileye Global (MBLY), with Tigress Financial highlighting a potential 178% upside. The autonomous driving tech firm posted double-digit growth in revenue and cash flow.
